Skip to main content
Fig. 4 | BMC Neuroscience

Fig. 4

From: Neuroprotective effects of HTR1A antagonist WAY-100635 on scopolamine-induced delirium in rats and underlying molecular mechanisms

Fig. 4

WAY-100635 reversed scopolamine-induced delirium-like behavior of rats. a Number of crossings, b number of rearing and c total distance moved during the 5 min session in the open field test, d Percentage of time spent in the open arms during the 5 min session in the elevated plus maze test, e total distance moved during the 10 min session in the light/dark test, f time spent in the open arms during the 10 min session in the light/dark test. Data are presented as mean ± SD. ***p < 0.001 by comparison against control rats and #p < 0.001 by comparison against scopolamine-treated rats

Back to article page